XRAY (Dentsply Sirona) Long-Term Debt: $2,006 Mil (As of Mar. 2026)


XRAY Dentsply Sirona Inc XRAY
51 GF Score
Price $11.65
GF Value $19.03
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Dentsply Sirona Long-Term Debt?

Dentsply Sirona XRAY +4.95% 51 Long-Term Debt is $2,006 Mil as of Mar. 2026. GuruFocus rates XRAY with a GF Score™ of 51/100 and a GF Value™ of $19.03 (Possible Value Trap). The stock has 5 warning signs investors should review.

Dentsply Sirona's Long-Term Debt for the quarter that ended in Mar. 2026 was $2,006 Mil.

Dentsply Sirona's quarterly Long-Term Debt declined from Sep. 2025 ($2,017 Mil) to Dec. 2025 ($2,015 Mil) and declined from Dec. 2025 ($2,015 Mil) to Mar. 2026 ($2,006 Mil).

Dentsply Sirona's annual Long-Term Debt declined from Dec. 2023 ($1,796 Mil) to Dec. 2024 ($1,586 Mil) but then increased from Dec. 2024 ($1,586 Mil) to Dec. 2025 ($2,015 Mil).

Dentsply Sirona  (NAS:XRAY) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Dentsply Sirona Long-Term Debt Related Terms

Dentsply Sirona Long-Term Debt Historical Data

* Premium members only.

The historical data trend for Dentsply Sirona's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Dentsply Sirona Long-Term Debt Chart

Dentsply Sirona Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Long-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,913.00 1,826.00 1,796.00 1,586.00 2,015.00

Dentsply Sirona Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,593.00 2,218.00 2,017.00 2,015.00 2,006.00
XRAY
51GF Score
Dentsply Sirona Inc XRAY
Long-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Long-Term Debt →
What does a Long-Term Debt of $2,006 Mil mean?
Dentsply Sirona (XRAY) has a Long-Term Debt of $2,006 Mil as of Mar. 2026.
Is Dentsply Sirona's Long-Term Debt too high?
Dentsply Sirona's current Long-Term Debt is $2,006 Mil. Overall, Dentsply Sirona has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dentsply Sirona's Long-Term Debt compare to LMAT and PLSE?
Dentsply Sirona's Long-Term Debt of $2,006 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Long-Term Debt for a Medical Devices & Instruments company?
A good Long-Term Debt depends on the Medical Devices & Instruments industry context. However, Long-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Long-Term Debt mean?
A high Long-Term Debt can signal that a stock is expensive relative to its fundamentals. Dentsply Sirona's current Long-Term Debt is $2,006 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dentsply Sirona stock overvalued right now?
Based on GuruFocus' analysis, Dentsply Sirona (XRAY) is currently considered Possible Value Trap. The stock's GF Value™ is $19.03, compared to a current price of $11.65 — trading 38.8% below its estimated fair value. The current Long-Term Debt is $2,006 Mil. Dentsply Sirona's overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Long-Term Debt calculated?
Long-Term Debt is calculated from a company's financial statements. For Dentsply Sirona (XRAY), the current Long-Term Debt is $2,006 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Dentsply Sirona (XRAY) Overvalued in 2026?

Based on GuruFocus' analysis, Dentsply Sirona stock appears to be undervalued. The current stock price of $11.65 is trading 38.8% below its estimated GF Value™ of $19.03. GuruFocus considers Dentsply Sirona to be Possible Value Trap.

Key valuation signals for XRAY:

  • Long-Term Debt: $2,006 Mil
  • GF Value™: $19.03 vs. price of $11.65 (38.8% below fair value)
  • GF Score™: 51/100 with 5 warning signs

No single metric tells the full story. See the XRAY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dentsply Sirona Business Description

Address 13320 Ballantyne Corporate Place, Charlotte, NC, USA, 28277-3607
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).
51GF Score

Get the complete analysis for XRAY

Long-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.65
Price
$19.03
GF Value